For så vidt angår aids- relateret Kaposis sarkom, blev virkningen af Caelyx undersøgt i to hovedundersøgelser med deltagelse af 384 patienter, herunder 77, der tidligere var blevet behandlet.
For AIDS-related Kaposi’ s sarcoma, the effectiveness of Caelyx was studied in two main studies involving 384 patients, including 77 who had received treatment before.